RTsafe announces first use of its PseudoPatient patient-specific quality assurance process by NSH CyberKnife Cancer Center, Dubai, UAE

RTsafe July 2023

Athens, Greece, 17 July 2023.  RTsafe, (www.rt-safe.com) the leading provider of quality assurance products and services in stereotactic radiosurgery, announces that UAE’s NSH CyberKnife Cancer Center at Neuro Spinal Hospital, Dubai (NSH – www.nshdubai.com) has conducted its first simulated therapy for multiple brain cavernomas using PseudoPatient, RTsafe’s patient-specific quality assurance process. This represents the first application of RTsafe’s PseudoPatient in the Gulf region.

DISCLAIMER: The statements and articles in the corporate news forum do not necessarily reflect the views of, and are not endorsed by ISRS.